Share this:
Clinical trial recruitment remains one of drug development’s greatest challenges. Despite decades of innovation, 80% of trials are delayed and 85% fail to meet enrollment goals (WCG Clinical) The result: delayed therapies, rising costs, and missed opportunities for patients who could benefit from new treatments.
Too often, patients simply aren’t aware that clinical trials are treatment options. More than half say they never hear about trial opportunities from their doctors (CISCRP). Empowering patients to find and understand these opportunities is key to transforming recruitment.
From Recruitment to Navigation
Traditional study-by-study recruitment focuses on a single trial. If a patient doesn’t qualify, their journey ends there.
“Patients shouldn’t reach a dead end when exploring trial options—they should be provided with next steps in their treatment journey.”Kyle SmithVice President, Sales at Carebox
Condition-based matching reframes recruitment as navigation, helping patients and their caregivers explore the full landscape of relevant trials within a sponsor’s portfolio, not just one trial at a time.
Continuous Engagement Through Condition-Based Matching
Most recruitment models end when a patient is screened out. If a participant doesn’t qualify, there’s no follow-up, just another dead end in a process that’s already difficult to navigate.
Condition-based matching eliminates those dead ends by keeping patients engaged and informed outside of a single trial. When patients complete a condition-match questionnaire, their responses not only identify current matches, but also connect them to a patient engagement registry that keeps them informed of new trial availability.
“Condition-based matching isn’t just about finding a match today—it’s about keeping patients connected to what’s next,” says Kyle Smith, VP of Sales at Carebox. “It transforms recruitment into an ongoing relationship, not a one-time transaction.”
For sponsors, this continuous engagement model means that when new studies are added, qualified, pre-engaged patients are already in the pipeline, helping accelerate recruitment, reduce startup time, and strengthen trust between patients and research organizations.
Condition-Based Matching Builds Trust with Patients
Trust remains one of the most significant barriers to clinical trial participation, especially among underrepresented communities. When patients are empowered to explore relevant options on their own terms, transparency improves—and so does trust.
Condition-based matching supports this by giving patients clarity, control, and credible connections to legitimate research opportunities, building confidence in both the process and the sponsors behind it. This inclusivity isn’t just ethical; it’s essential to achieving representative, successful trials.
A Smarter Way Forward
Empowering patients with tools to explore relevant clinical trials benefits everyone. By implementing condition-based matching, sponsors can:
- Streamline recruitment by reducing redundancy and improving referral quality.
- Accelerate timelines with more qualified participants from the start.
- Build lasting relationships that support future trials across the portfolio.
When clinical trials evolve from one-time recruitment to continuous engagement, everyone wins—patients gain access to potential treatment options, and sponsors achieve their recruitment goals more efficiently.
Explore more about how condition-based matching is changing clinical trial recruitment in our related article:
Can Condition-Based Matching Shift the Clinical Trial Recruitment Paradigm?
